Immune system alterations could provide a path for future diagnostics and studies of this progressively debilitating neurological disease
Category Archives: AZBio News
Humabiologics & Allegro 3D partner to provide human bioinks for rapid high throughput bioprinting and tissue models
The convergence of the world’s first human bioinks and the most advanced digital light processing (DLP)-based bioprinter for direct printing in multiwell plates will accelerate high-throughput manufacturing of advanced human tissues for cell culture, drug screening, therapeutics and regenerative medicine. Continue reading
Helios Scholars at TGen learn teamwork, technique and tenacity
Aug. 3 symposium caps 8-week internship of real-life biomedical research sponsored by Helios Education FoundationContinue reading
CyVerse Receives $1.3M to Provide Cyberinfrastructure and Training for New NSF Artificial Intelligence Institute
CyVerse will provide computational infrastructure, data science and education to integrate the efforts of other partners of the NSF’s new AI Institute for Resilient Agriculture.
Governor Ducey Thanks ADHS Director Dr. Christ For Longtime, Dedicated Service To Arizona
Dr. Christ, Longest-Serving ADHS Director, To Join Blue Cross Blue Shield Of ArizonaContinue reading
Tiny Wireless Device Illuminates Neuron Activity in the Brain
A less invasive optogenetic device takes researchers a step closer to new treatments for chronic pain, depression, epilepsy and more.
Generate Life Sciences Establishes Newborn Stem Cell Manufacturing Facility to Support the Development of Personalized Therapeutics
The facility bolsters the company’s existing stem cell research and repository capabilities with mesenchymal stem cell (MSC) biologics manufacturing
2021 Arizona Innovation Challenge
ARIZONA COMMERCE AUTHORITY IS NOW ACCEPTING APPLICATIONS FOR THE 2021 ARIZONA INNOVATION CHALLENGE
Governor Ducey Statement On Importance Of COVID-19 Vaccination
Governor Ducey: “Today, thanks to the miracle of modern science, we have something we didn’t have last year: a vaccine.”
Ivy Brain Tumor Center Announces Plan to Build New Global Headquarters in Phoenix
Facility Marks Largest Translational Research Center Dedicated to Brain Tumor Drug Development and Treatment Worldwide